BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10443052)

  • 1. Rest-injected 201thallium in the evaluation of myocardial viability.
    Perrone-Filardi P; Dellegrottaglie S; Chiariello M
    Cardiologia; 1999 Jun; 44(6):515-20. PubMed ID: 10443052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thallium scintigraphy for determining myocardial vitality. Evaluation of the "stunned and hibernating myocardium"].
    Nienaber CA; Carnarius H
    Herz; 1994 Feb; 19(1):7-18. PubMed ID: 8150416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial viability in ischemic heart disease: new directions and perspectives.
    Previtali M
    Ital Heart J; 2001 Feb; 2(2):93-9. PubMed ID: 11256549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversible dysfunction of the left ventricle in coronary disease (part two): hibernation and methods for detection of viability].
    Vlahović A; Popović A
    Med Pregl; 2000; 53(3-4):146-53. PubMed ID: 10965679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morpho-functional diagnostic imaging in the assessment of viable myocardium in patients with ischemic heart disease. Correlations between myocardial perfusion and regional function of the left ventricle].
    Cuocolo A; Pace L; Maurea S; Nappi A; Nicolai E; Imbriaco M; Sullo P; Cardei S; Salvatore M
    Radiol Med; 1995 Jun; 89(6):870-5. PubMed ID: 7644745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of dobutamine stress echocardiography in myocardial viability.
    Schinkel AF; Poldermans D; Elhendy A; Bax JJ
    Curr Opin Cardiol; 2006 Sep; 21(5):443-9. PubMed ID: 16900006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of hibernating myocardium with NOGA electroanatomic endocardial mapping.
    Gyöngyösi M; Khorsand A; Sochor H; Sperker W; Strehblow C; Graf S; Binder T; Glogar D
    Am J Cardiol; 2005 Mar; 95(6):722-8. PubMed ID: 15757597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic ischemic left ventricular dysfunction: myocardial hibernation?].
    Monin JL; Duval AM; Garot J; Guéret P
    Arch Mal Coeur Vaiss; 2000 Mar; 93(3):291-9. PubMed ID: 11004976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of myocardial viability: review of the clinical significance.
    Ramos M; DePasquale E; Coplan NL
    Rev Cardiovasc Med; 2008; 9(4):225-31. PubMed ID: 19122580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myocardial viability in man: state of the art and directions to pursue].
    Vanoverschelde JL
    Bull Mem Acad R Med Belg; 1999; 154(1):91-6; discussion 96-8. PubMed ID: 10535159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of myocardial viability in chronic ischemic heart disease: current status.
    Rizzello V; Poldermans D; Bax JJ
    Q J Nucl Med Mol Imaging; 2005 Mar; 49(1):81-96. PubMed ID: 15724138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of myocardial viability as determined by rest-redistribution 201Tl single photon emission CT imaging and the choice of therapy on prognosis in patients with left ventricular dysfunction.
    Shapira I; Heller I; Pines A; Topilsky M; Isakov A
    J Med; 2000; 31(3-4):205-14. PubMed ID: 11280452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonstress delayed-enhancement magnetic resonance imaging of the myocardium predicts improvement of function after revascularization for chronic ischemic heart disease with left ventricular dysfunction.
    Schvartzman PR; Srichai MB; Grimm RA; Obuchowski NA; Hammer DF; McCarthy PM; Kasper JM; White RD
    Am Heart J; 2003 Sep; 146(3):535-41. PubMed ID: 12947375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiology of myocardial hibernation: current controversies and future directions.
    Vanoverschelde JL; Melin JA
    Prog Cardiovasc Dis; 2001; 43(5):387-98. PubMed ID: 11251126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of prognostic value of 99mTc MIBI rest, 18F FDG and 201TL rest/redistribution on PTCA outcome of patients with moderate left ventricle dysfunction.
    Rossetti C; Landoni C; Lucignani G; Garraffa G; Ippolito M; Pepi M; Bartorelli A; Guazzi M; Savi A; Fazio F
    Panminerva Med; 1999 Sep; 41(3):199-206. PubMed ID: 10568116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible myocardial dysfunction: basics and evaluation.
    Gowda RM; Khan IA; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Dec; 97(3):349-53. PubMed ID: 15561318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting recovery of regional left ventricular function after revascularization?
    Kitsiou AN; Srinivasan G; Quyyumi AA; Summers RM; Bacharach SL; Dilsizian V
    Circulation; 1998 Aug; 98(6):501-8. PubMed ID: 9714106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial viability: known and unknown.
    Bax JJ; Poldermans D; Rambaldi R; Valkema R; Slavich GA; Fioretti PM
    G Ital Cardiol; 1998 Mar; 28(3):229-36. PubMed ID: 9561876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment of myocardial viability and hibernation using resting thallium imaging.
    Perrone-Filardi P; Chiariello M; Underwood R
    Clin Cardiol; 2000 Oct; 23(10):719-22. PubMed ID: 11061048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electromechanical mapping for detecting myocardial viability and ischemia in patients with severe ischemic cardiomyopathy.
    Samady H; Liu YH; Choi CJ; Ragosta M; Pfau SE; Cleman MW; Powers ER; Kramer CM; Wackers FJ; Beller GA; Watson DD
    Am J Cardiol; 2003 Apr; 91(7):807-11. PubMed ID: 12667565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.